Skip to content

Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit

Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04160039
Enrollment
97
Registered
2019-11-12
Start date
2019-11-10
Completion date
2022-09-01
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Acquired Weakness, Liver Cirrhoses, Liver Failure

Keywords

Cycle Ergometry, Physical Therapy, Rehabilitation

Brief summary

Critically-ill patients with liver disease are at high risk of developing sarcopenia and intensive care unit (ICU)-acquired weakness, which are associated with mortality and other poor outcomes. Early physical rehabilitation has shown benefit in ICU settings, but has not been studied in ICU patients with acute and chronic liver failure. Cycle ergometry, or stationary cycling in passive and active modes, may be especially beneficial to such patients due to their high prevalence of severe physical deconditioning and variable mentation. The aim of this study is to examine the feasibility, safety, and benefit of cycle ergometry over standard physical and occupational therapy (PT/OT) in critically-ill patients who have acute or chronic liver disease.

Detailed description

A single-blinded randomized controlled trial will be conducted in a transplant intensive care unit (TICU). Eligible adult patients will be enrolled within 72 hrs after TICU admission and randomly allocated to either (1) standard PT/OT care, or (2) PT/OT care and cycle ergometry sessions with trained PT/OT therapists or technicians. The outcome measures, tests of strength and function, will be assessed at baseline, every 14 days, and upon TICU discharge by a blinded PT/OT therapist.

Interventions

Lower extremity cycle ergometry, passive and/or active, up to 20 minutes per session, up to 5 sessions per week

Sponsors

Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults 18 ≥ years with acute or chronic liver disease admitted to Transplant Intensive Care Unit (TICU), or admitted to TICU following a liver or liver-kidney transplant * Expected to remain in ICU for ≥ 5 days * Spoken English fluency

Exclusion criteria

* Known primary systemic neuromuscular disease or intracranial process causing increased intracranial pressure * Lower extremity amputation * Anticipated death or palliative withdrawal of life support within 5 days * Cycle ergometer weight limit (135 kg or 297.6 lbs per manufacturer)

Design outcomes

Primary

MeasureTime frameDescription
Functional Status Score for the Intensive Care Unit (FSS-ICU)Through study completion, average of 1 yearStandardized assessment tool for functional status in ICU patients. Score ranges from 0 (unable to perform) to 35 (highest function).

Secondary

MeasureTime frameDescription
Number of participants who experience an adverse event during therapyThrough study completion, average of 1 yearTotal number of participants who experience an adverse event during PT/OT and cycling sessions during course of study
Duration of mechanical ventilationThrough study completion, average of 1 yearAverage number of days on mechanical ventilation
ICU length of stayThrough study completion, average of 1 yearAverage length of stay in days
Number of participants who experience ICU readmissionThrough study completion, average of 1 yearTotal number of participants readmitted to ICU during study period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026